Bsenexus Terminal Open in Bsenexus App →
BOARD_MEETING BSE: 544529

Aptus Pharma Ltd

Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30, 2026 And Closure Of Trading Window

Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2026 ,inter alia, to consider and approve Board Meeting Intimation for consideration ....